
Lirafugratinib + LITESPARK011
OncoPharm
00:00
FGFR Inhibitor Responses And Common Toxicities
John Bazar reviews similar response rates across FGFR inhibitors and describes lirafugratinib’s frequent nail, hand-foot, skin, hair, and eye toxicities.
Play episode from 03:02
Transcript


